Related Experiment Video

Updated: Jun 16, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Advantage of MIDAM protocol in treatment of elderly patients with refractory and relapsing acute myeloid leukemia

Kalman Filanovsky, Lev Shvidel, Mordechai Shtalrid

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|January 27, 2010

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

British journal of haematology·2026

Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL.

Blood advances·2025

Anaemia of Inflammation Preceding Dyspnoea, Dry Cough and Weight Loss in Primary Pulmonary Lymphoma.

European journal of case reports in internal medicine·2025

The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group.

Acta haematologica·2023

MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level.

Journal of clinical medicine·2023

All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia.

Journal of clinical medicine·2023

See all related articles